Loading clinical trials...

Kazakh Version of Reflux Symptom Index | Clinical Trials | Clareo Health

COMPLETED

Kazakh Version of Reflux Symptom Index

Validity and Reliability of a Kazakh Version of Reflux Symptom Index

NCT05296655•Kazakh Medical University of Continuing Education

Summary

Reflux symptoms index (RSI) were developed to identify a clinical index of suspicion for laryngopharyngeal reflux (LPR) in patients with ear, nose, and throat symptoms. RSI is an efficient diagnostic tool for LPR/ It is easy to use, even for those who know little about LPR. It does not require special equipment or examinations and is inexpensive. Thus, it can be considered highly efficient and cost-effective. The study will focus on translating and testing the RSI into Kazakh language and comparing its results in healthy people and people with laryngopharyngeal reflux.

Eligibility

Age

18 - 74 years

Sex

ALL

Healthy Volunteers

Yes

Inclusion Criteria

•Patient's informed consent;
•Age: 18-74 years old;
•No serious somatic diseases;
•Patients with complaints of sore throat, coughing, burning sensation in the throat, coughing, frequent sore throat, difficulty swallowing, lump in the throat, foreign body feeling in the throat, voice changes, heartburn and belching;
•Diagnosis: Chronic pharyngitis;
•Chronic laryngitis.

Exclusion Criteria

•Disagreement to participate in scientific research;
•Age: under 18 and over 74;
•Severe somatic diseases, organic lesions of the gastrointestinal tract and ENT organs;
•Patients with pulmonary pathologies;
•Patients with allergic manifestations (chronic or allergic rhinosinusitis and nasal polyposis);
•With diagnoses: Acute respiratory diseases;
•Patients with general neuralgic disorders;
•Pregnancy;
•Benign lesions of the vocal cords;
•Acid-suppressive therapy within 4 weeks prior to recruitment

Locations (2)

SOS Medical Assistance

Almaty, Kazakhstan

V-ent

Almaty, Kazakhstan

Key Dates

Start Date

March 1, 2020

Primary Completion Date

February 15, 2022

Completion Date

February 16, 2022

Last Updated

May 23, 2022

Enrollment

248

ACTUAL participants

Conditions

Laryngopharyngeal Reflux SymptomsLaryngopharyngitis ChronicGastro Esophageal Reflux Disease

Interventions

Reflux Symptom Index Inventory (diagnostic survey)

OTHER

Reflux finding score

OTHER

Endoscopic Treatment of Gastroesophageal Reflux Disease

NCT05678491

Gastro Esophageal Reflux Disease

View study

UNKNOWNNA

Effect of Routine Anterior Crural Repair in De-Novo Gastroesophageal Reflux After Laparoscopic Sleeve Gastrectomy

NCT04884074

ObesityGastro Esophageal Reflux Disease

View study

WITHDRAWN

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: May 23, 2022Data synced to Clareo: March 29, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions

Kazakh Version of Reflux Symptom Index

Inclusion Criteria

Exclusion Criteria

Endoscopic Treatment of Gastroesophageal Reflux Disease

Effect of Routine Anterior Crural Repair in De-Novo Gastroesophageal Reflux After Laparoscopic Sleeve Gastrectomy

A Prospective, Observational Study of the PPI Non-responder